CTLA-4 and CD28 gene polymorphisms in susceptibility, clinical course and progression of multiple sclerosis

Author： van Veen T. Crusius J.B.A. van Winsen L. Xia B. Barkhof F. Salvador Pena A. Polman C.H. Uitdehaag B.M.J.

Publisher： Elsevier

ISSN： 0165-5728

Source： Journal of Neuroimmunology, Vol.140, Iss.1, 2003-07, pp. : 188-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CTLA-4 and MCP-1 Polymorphisms and Susceptibility to Systemic Sclerosis: a Meta-analysis

By Song Gwan Gyu Lee Young Ho

Immunological Investigations, Vol. 42, Iss. 6, 2013-08 ,pp. : 481-492

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of the Progression of Multiple Sclerosis by Linomide Is Associated with Upregulation of CD4+/CD45RA+ Cells and Downregulation of CD4+/CD45RO+ Cells

By Lehmann D. Karussis D. Mizrachi-Koll R. Linde A.S. Abramsky O.

Clinical Immunology, Vol. 85, Iss. 2, 1997-11 ,pp. : 202-209

Academic Press

Access to resources Recommend Favorite

CTLA-4 Gene Polymorphisms in Tunisian Patients with Graves' Disease

By Hadj Kacem H. Bellassoued M. Bougacha-Elleuch N. Abid M. Ayadi H.

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 361-365

Academic Press

Access to resources Recommend Favorite

The Role of CTLA-4 Gene Polymorphisms in Autoimmune Disease Pathogenesis: A 2012 Update

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 13, Iss. 2, 2013-06 ,pp. : 89-96

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of CD28, CTLA4, CD80, and CD86 Molecules in Patients with Autoimmune Rheumatic Diseases: Implications for Immunotherapy

By Sfikakis P.P. Via C.S.

Clinical Immunology, Vol. 83, Iss. 3, 1997-06 ,pp. : 195-198

Academic Press

Access to resources Recommend Favorite